LVGI News 0.0017 05/22/2014 05:10:26 Limitless Venture Group

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Limitless Venture Group Inc. (LVGI) 0.0017 $LVGI

Limitless Venture Group Inc. Announces Official Launch of HYPERLINK "http://www.hempcorehealth.com" www.hempcorehealth.com
Marketwire - Mon May 19, 8:16AM CDT
Limitless Venture Group Inc's. (PINKSHEETS: LVGI) today announced the official launch of HYPERLINK "http://www.hempcorehealth.com" www.hempcorehealth.com. The site contains full information on LVGI's HempCore Health(TM) line of products. The initial product lineup consists of five products.

Bioflamex Corp Sees Huge Spike In Share Volume May 12th
ACCESSWIRE - Tue May 13, 8:58AM CDT
Bioflamex Corp (OTCPINK: BFLX) saw its share volume skyrocket on May 12th with 426,772,736 shares exchanging hands, more than thirty-two times higher than its three month daily average of 13,008,179 shares.

Limitless Venture Group Inc. Would Like to Update All Shareholders of Its Former Subsidiary Genetically Enhanced Athletic Research Inc. (G.E.A.R.) That Sales Are Going Very Well in USA and Europe
Marketwire - Tue May 13, 8:16AM CDT
Limitless Venture Group Inc. (OTC Pink: LVGI) (PINKSHEETS: LVGI) today announced that sales of its former subsidiary G.E.A.R.(TM) since recently launching nationally in Vitamin Shoppes(TM) across the USA and via G.E.A.R.(TM) Europe are going very well. Reorders are already coming in and demand is high. New product offerings are fully developed and will hit the production line this quarter.

Vapor Group Inc. to Showcase New Vaporizers at the High Times' U.S. Cannabis Cup
ACCESSWIRE - Thu Apr 17, 8:19AM CDT
On Apr. 16, Vapor Group, Inc., formerly AvWorks Aviation Corp., (OTCQB: SPLI) stock volume soared, with 47,892,751 changing hands, nearly three times its three-month average volume of 16,622,807 shares.

Limitless Venture Group Settles $163,391 Note with Beaufort Capital Partners
ACCESSWIRE - Wed Apr 16, 9:07AM CDT
Limitless Venture Group Inc.'s (OTCPINK: LVGI) announced that the company and a third- party debt holder Beaufort Capital Partners reached an amicable settlement regarding an outstanding note which had essentially floorless convertible terms attached.

Limitless Venture Group Inc. Announces It Has Acquired the Funding for First Round of SLAM Production
Marketwire - Wed Apr 16, 8:15AM CDT
Limitless Venture Group Inc. (PINKSHEETS: LVGI) (OTC Pink: LVGI) today announced that it has now acquired the funding for the first production of SLAM. We are re-engaging with MANGO Bottling from Florida to discuss a bottling schedule. MANGO still holds the COLA licenses to run SLAM. COLA's are the label approvals needed to bottle an alcohol product. LVGI owns them but they need to registered by the manufacturing plant that will bottle the product.

Limitless Venture Group Inc. Announces It Has Settled Debt Holder Dispute
Marketwire - Mon Apr 14, 8:40AM CDT
Limitless Venture Group Inc. (OTC Pink: LVGI) (PINKSHEETS: LVGI) today announced that the company and a third party debt holder Beaufort Capital Partners reach an amicable settlement regarding an outstanding note which had essentially floorless convertible terms attached, the parties agreed to a two tranche fixed conversion to settle in its entirety a $163,391.00 note balance, for a total of 273,257,143 shares.

Limitless Venture Group Inc. Would Like to Inform All Shareholders of Its Former Subsidiary Genetically Enhanced Athletic Research Inc. (G.E.A.R.) Officially Launched in Europe
Marketwire - Tue Apr 08, 8:20AM CDT
Limitless Venture Group Inc. (OTC Pink: LVGI) (PINKSHEETS: LVGI) today announced that its former subsidiary G.E.A.R., which LVGI shareholders still own a minority interest in through a joint venture with Fitness Authority from Poland, officially launched G.E.A.R. EUROPE at the FIBO expo this past weekend in Cologne, Germany. The expo was a huge success and reaction to G.E.A.R. was incredible. Through the joint venture all G.E.A.R. products will be manufactured by Fitness Authority in Poland. G.E.A.R. EUROPE will be available in Europe, Middle East, North Africa (Tunisia, Morocco, Egypt, Libya, and Algeria), Asia, India, Sri-Lanka, Kazakhstan, Turkey, Russia, Afghanistan and the Scandinavian Countries.

Limitless Venture Group Inc. Would Like to Inform All Shareholders of Its Former Subsidiary Genetically Enhanced Athletic Research Inc. (G.E.A.R.) That Product to Be Shipped to Vitamin Shoppe on Wednesday April 9, 2014
Marketwire - Wed Apr 02, 10:30AM CDT
Limitless Venture Group Inc's. (OTC Pink: LVGI) (PINKSHEETS: LVGI) today announced that its former subsidiary G.E.A.R. to ship large order to Vitamin Shoppe on Wednesday April 9, 2014. G.E.A.R. Shock Series product line to be available at every Vitamin Shoppe across the USA. The G.E.A.R. team also will be in attendance from April 3-7th at the FIBO expo in Cologne, Germany for the launch of G.E.A.R. Europe. Other developments include the finalization of distribution by BodyBuilding.com worlds #1 online retailer of sports nutrition and Nutrition Express another powerhouse online distributor. A lot more to come from G.E.A.R.

Limitless Venture Group's Stock Volume Soars On News of Hemp-Based Products
ACCESSWIRE - Wed Apr 02, 8:41AM CDT
Limitless Venture Group Inc.'s (OTCPINK: LVGI) stock volume skyrocketed Apr. 1, with 292,012,825 shares changing hands, nearly three times more than its three-month average volume of 107,767,353 shares.

Ku6 Media Co. Controlling Shareholder to Sell 41% Stake to Xu Xudong; Limitless Venture Group Announces The HempCore Health Series
ACCESSWIRE - Tue Apr 01, 11:41PM CDT
McDermott International Inc. (NYSE: MDR) - For an in-depth report on McDermott International Inc. follow: www.BullTrends.com/stockquote/MDR

Limitless Venture Group Inc. Announces Through Its Limitless Health Products Division The HempCore(TM) Health Series
Marketwire - Tue Apr 01, 8:15AM CDT
Limitless Venture Group Inc. (OTC Pink: LVGI) (PINKSHEETS: LVGI) today announced that in response to the ever popular industry trend and overwhelming suggestions from consumers and shareholders alike LVGI through its Limitless Health division has developed and about to enter into production on a line of HEMP based health products called The HempCore(TM) Health Series. This will be a series of four products all based around the health benefits derived from the use of HEMP as the main ingredient. One product will be aimed as heart health and cholesterol reduction, one towards joint pain/arthritis relief, one for brain health/cognitive function and one for anxiety relief.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 61

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 144

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Air Sealing First: Boosting Home Comfort & Efficiency

Updated Category News Views 69

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 181

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 28

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 80

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 149

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 252

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 96

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 331

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Warner Bros. Discovery's Remarkable Stock Surge Explained

Updated Category News Views 309

Warner Bros. Discovery Experiences Impressive Stock Surge Warner Bros. Discovery Inc. (NASDAQ: WBD) has been making headlines recently, with its stock surging dramatically. Investors and market enthusiasts are keenly observing this upward trend, particularly following a substantial rally. Record-Breaking Rally The company achieved an incredible milestone with its largest...

Continue Reading
Stellantis Reports 20% Q3 Shipment Drop, Market Reactions

Updated Category News Views 98

Stellantis Faces Significant Q3 Shipment Decline Stellantis (EPA: STLAM) (NYSE: STLA) recently reported a 20% drop in global shipments for the third quarter, prompting a notable reaction in the markets. The decline has been attributed to several factors including strategic inventory reduction measures and delays in the release of new models. During this challenging...

Continue Reading
Stifel Affirms Buy Rating on Elanco Amid New Drug Approval

Updated Category News Views 70

Stifel Stands Firm on Elanco Animal Health Stifel, a prominent financial services firm, has recently reaffirmed its Buy rating for Elanco Animal Health (NYSE: ELAN) and has kept its price target at $20.00 per share. This decision comes on the heels of the U.S. Food and Drug Administration's (FDA) approval of Elanco's new drug, Zenrelia, which serves as a significant boost...

Continue Reading
ChargePoint and Siemens Drive EV Infrastructure Innovation

Updated Category News Views 94

ChargePoint and Siemens Lead the Charge in Clean Tech The clean tech revolution is moving at an impressive pace, particularly with the growth of electric vertical takeoff and landing (eVTOL) aircraft and electric vehicle (EV) infrastructure. Companies like ChargePoint Holdings Inc (NYSE: CHPT) and Siemens AG (OTCPK: SIEGY) are crucial in shaping a sustainable future for...

Continue Reading
Elevance Health Faces Class Action: Investors Seek Remedies

Updated Category News Views 259

Opportunities for Investors in Elevance Health Class Action The recent developments surrounding Elevance Health, Inc. have prompted considerable attention, particularly among investors who have experienced substantial financial losses. The law firm Robbins Geller Rudman & Dowd LLP has initiated a class action lawsuit targeting Elevance Health, which operates in the health...

Continue Reading